EFFECT OF CISTANCHE MONGOLICA EXTRACT ON THE CENTRAL NERVOUS SYSTEM AND ITS PSYCHOPHARMACOLOGICAL PROPERTIES

Relevance. Depression is often accompanied by anxiety, psychomotor retardation and impaired cognitive function. A new psychotropic agent should therefore be assessed not only for antidepressant activity but also for its effects on behaviour, anxiety and neurotransmitter systems. Plants of the genus Cistanche are known for their neuroprotective properties, but the effects of C. mongolica, which grows in the deserts of the Fergana region and Karakalpakstan, on the central nervous system have not been studied before. Aim – to study the effects of Cistanche mongolica extract on locomotor activity, anxiety and the dopaminergic system in experimental animals. Materials and methods. Experiments were performed on male white mice (18–24 g). An extract of the aerial and underground parts of C. mongolica was administered orally at doses of 50, 100 and 200 mg/kg. The following methods were used: phenamine (amphetamine)-induced locomotor activity (7 mg/kg, s.c.), recorded over 4 hours; open field test (Hall C.); light–dark box test against pentylenetetrazole (20 mg/kg, s.c.); haloperidol-induced catalepsy (1.0 mg/kg, s.c.), recorded over 5 hours. Data were analysed using Student's t-test; differences at p≤0.05 were considered significant. Results. In the control group, phenamine increased locomotor activity to 152–160% of baseline at 1–3 hours. In the extract-treated groups this value fell to 74–111% at 3–4 hours (p≤0.05). The strongest effect was seen at 200 mg/kg: 106% at 2 hours versus 160% in the control group. In the open field test, locomotor activity was 9.2±1.3 in the control group, 14.6±2.8 at 50 mg/kg and 16.8±2.9 at 200 mg/kg (p≤0.05). At 200 mg/kg, exploratory activity also increased (11.2±2.7 vs 9.4±1.5). Rearing was recorded only at 100 and 200 mg/kg. The number of defecations decreased at all doses (0–1.0 vs 2.5). In the light–dark box test, pentylenetetrazole reduced the ratio of time spent in the light and dark compartments (K) to 0.31; in intact animals it was 0.49. With the extract, K was 1.34, 1.60 and 1.52 (p≤0.05), i.e. 4.3–5.2 times higher than in the control group. Haloperidol induced catalepsy lasting 58–120 s in the control group. At 50 mg/kg, the extract shortened catalepsy to 0–18 s (p≤0.05). At 100 and 200 mg/kg, catalepsy also remained significantly shorter than in the control group throughout the 5 hours (5–45 s and 0–65 s, respectively). Conclusion. Cistanche mongolica extract has a modulating effect on the central nervous system. It increases locomotor and exploratory activity but attenuates phenamine-induced hyperactivity. The extract shows marked anxiolytic activity and a dopamine-positive effect. These properties complement its antidepressant action and point to its potential use in depressive states accompanied by anxiety.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-30
DOI
https://doi.org/10.5281/zenodo.23806077
Primary Topic
Medicinal Plant Extracts Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EFFECT OF CISTANCHE MONGOLICA EXTRACT ON THE CENTRAL NERVOUS SYSTEM AND ITS PSYCHOPHARMACOLOGICAL PROPERTIES

N.F. Rakhimova, N.M. Mamatova
2 links
Zenodo (CERN European Organization for Nuclear Research)
Medicinal Plant Extracts Effects
article

EFFECT OF CISTANCHE MONGOLICA EXTRACT ON THE CENTRAL NERVOUS SYSTEM AND ITS PSYCHOPHARMACOLOGICAL PROPERTIES

N.F. Rakhimova, N.M. Mamatova
article en

Abstract

Relevance. Depression is often accompanied by anxiety, psychomotor retardation and impaired cognitive function. A new psychotropic agent should therefore be assessed not only for antidepressant activity but also for its effects on behaviour, anxiety and neurotransmitter systems. Plants of the genus Cistanche are known for their neuroprotective properties, but the effects of C. mongolica, which grows in the deserts of the Fergana region and Karakalpakstan, on the central nervous system have not been studied before. Aim – to study the effects of Cistanche mongolica extract on locomotor activity, anxiety and the dopaminergic system in experimental animals. Materials and methods. Experiments were performed on male white mice (18–24 g). An extract of the aerial and underground parts of C. mongolica was administered orally at doses of 50, 100 and 200 mg/kg. The following methods were used: phenamine (amphetamine)-induced locomotor activity (7 mg/kg, s.c.), recorded over 4 hours; open field test (Hall C.); light–dark box test against pentylenetetrazole (20 mg/kg, s.c.); haloperidol-induced catalepsy (1.0 mg/kg, s.c.), recorded over 5 hours. Data were analysed using Student's t-test; differences at p≤0.05 were considered significant. Results. In the control group, phenamine increased locomotor activity to 152–160% of baseline at 1–3 hours. In the extract-treated groups this value fell to 74–111% at 3–4 hours (p≤0.05). The strongest effect was seen at 200 mg/kg: 106% at 2 hours versus 160% in the control group. In the open field test, locomotor activity was 9.2±1.3 in the control group, 14.6±2.8 at 50 mg/kg and 16.8±2.9 at 200 mg/kg (p≤0.05). At 200 mg/kg, exploratory activity also increased (11.2±2.7 vs 9.4±1.5). Rearing was recorded only at 100 and 200 mg/kg. The number of defecations decreased at all doses (0–1.0 vs 2.5). In the light–dark box test, pentylenetetrazole reduced the ratio of time spent in the light and dark compartments (K) to 0.31; in intact animals it was 0.49. With the extract, K was 1.34, 1.60 and 1.52 (p≤0.05), i.e. 4.3–5.2 times higher than in the control group. Haloperidol induced catalepsy lasting 58–120 s in the control group. At 50 mg/kg, the extract shortened catalepsy to 0–18 s (p≤0.05). At 100 and 200 mg/kg, catalepsy also remained significantly shorter than in the control group throughout the 5 hours (5–45 s and 0–65 s, respectively). Conclusion. Cistanche mongolica extract has a modulating effect on the central nervous system. It increases locomotor and exploratory activity but attenuates phenamine-induced hyperactivity. The extract shows marked anxiolytic activity and a dopamine-positive effect. These properties complement its antidepressant action and point to its potential use in depressive states accompanied by anxiety.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 7%
Medicinal Plant Extracts Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon